Urothelial-cell carcinoma and solitary kidney: Outcomes with renal-sparing management

Journal of Endourology

Volumn 20, Issue 10, 2006, Pages 800-807

  Milner, John E ^a   Voelzke, Bryan B ^a   Flanigan, Robert C ^a   Sharma, Sameer K ^a   Perry Jr , Kent T ^a   Turk, Thomas M T ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; KIDNEY FAILURE; MALE; METASTASIS; MORBIDITY; NEPHRON SPARING SURGERY; NEPHROSTOMY; NEPHROURETERECTOMY; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; REVIEW; SOLITARY KIDNEY; SURGICAL TECHNIQUE; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; UROGENITAL TRACT TUMOR; UROTHELIUM CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS; SURVIVAL ANALYSIS;

EID: 33750945283     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2006.20.800     Document Type: Review

References (13)

1. Lam JS, Gupta M. Ureteroscopic management of upper tract transitional cell carcinoma. Urol Clin North Am 2004;31: 115-128.
2. Donat SM, Herr HW. Transitional cell carcinoma of the renal pelvis and ureter: diagnosis, staging, management, and prognosis. In: Urologic Oncology. Philadelphia: WB Saunders, 1997, pp 235-245.
3. Soderdahl DW, Fabrizio MD, Rahman NU, Jarrett TW, Bagley DH. Endoscopic treatment of upper tract transitional cell carcinoma. Urol Oncol 2005;23:114-122.
4. Lee BR, Jabbour ME, Marshall FF, Smith AD, Jarrett TW. 13-Year survival comparison of percutaneous and open nephroureterectomy I approaches for management of transitional cell carcinoma of renal collecting system: Equivalent outcomes. J Endourol 1999;13:289-294.
5. Jabbour ME, Smith AD. Primary percutaneous approach to upper urinary tract transitional cell carcinoma. Urol Clin North Am 2000;27:739-750.
6. Deligne E, Colombel M, Badet L, et al. Conservative management of upper urinary tract tumors. Eur Urol 2002;42:43-48.
7. Thalmann GN, Markwalder R, Walter B, Studer UE. Long-term experience with BCG therapy of upper tract transitional cell carcinoma in patients not eligible for surgery. J Urol 2002; 168(4 Pt 1):1381-1385.
8. Vasavada SP, Streem SB, Novick AC. Definitive tumor resection I and percutaneous BCG for management of renal pelvic TCC in solitary kidneys. Urology 1995;45:381-386.
9. Patel A, Fuchs GJ. New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract TCC. J Urol 1998;159:71-75.
10. Daneshmand S, Quek ML, Huffman JL. Endoscopic management of upper urinary tract transitional cell carcinoma: Long-term experience. Cancer 2003;98:55-60.
11. Mailloux LU, Bellucci AG, Wilkes BM, Napolitano B, Mossey RT, Lesser M, Bluestone PA. Mortality in dialysis patients: Analysis of the causes of death. Am J Kidney Dis 1991;18:326-335.
12. Iseki K, Tozawa M, Takishita S. Effect of duration of dialysis on survival in a cohort of chronic hemodialysis patients. Nephrol Dial Transplant 2003;18:782-787.
13. Chertow GM, Johansen KL, Lew N, et al. Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int 2000;57: 1176-1181.